Inovio Pharmaceuticals, Inc. IPO Research Information

Inovio Pharmaceuticals, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Inovio Pharmaceuticals, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Inovio Pharmaceuticals, Inc.	INO -	Last trade $3.76	$3.00	$0.00	10 million	12/13/2024
Underwriter(s): Oppenheimer, Citizen JMP
Co-Manager(s): Stephens
Industry:
Filing(s):

Inovio Pharmaceuticals, Inc. Quote & Chart - Click for current quote - INO

About Inovio Pharmaceuticals, Inc. (adapted from Inovio Pharmaceuticals, Inc. prospectus):
They are a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat, cure and protect people from diseases associated with human papillomavirus, or HPV, cancer and infectious diseases.

This description is adapted from Inovio INO prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Inovio INO "INO" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.